From: A novel signature based on microvascular invasion predicts the recurrence of HCC
Charcateristic | Multivariable analysis | |||||
---|---|---|---|---|---|---|
Coef | HR | Lower 95 | Upper 95 | z | P value | |
Discovery set (n = 271) | ||||||
Risk sore | 1.0001 | 2.7186 | 2.1975 | 3.3633 | 9.2118 | 3.21E−20 |
Age_ ≥ 65/, < 65 | 0.2566 | 1.2925 | 0.8791 | 1.9005 | 1.3048 | 0.1919 |
Gender | − 0.0778 | 0.9251 | 0.6121 | 1.398 | − 0.3694 | 0.7118 |
Neoplasm-histologic-grade | − 0.1161 | 0.8903 | 0.6956 | 1.1394 | − 0.9228 | 0.3561 |
Pathologic_M | 0.066 | 1.0683 | 0.863 | 1.3224 | 0.6071 | 0.5437 |
Pathologic_N | 0.1106 | 1.117 | 0.911 | 1.3695 | 1.0639 | 0.2873 |
Pathologic_T | 0.0183 | 1.0185 | 0.8327 | 1.2457 | 0.1785 | 0.8583 |
Pathologic_stage | 0.0231 | 1.0234 | 0.8378 | 1.2501 | 0.2268 | 0.8205 |
Validation set (n = 401) | ||||||
Riskscore | 0.96 | 2.6117 | 1.5394 | 4.4308 | 3.5597 | 0.0004 |
Age | − 0.1479 | 0.8625 | 0.6456 | 1.1523 | − 1.0007 | 0.317 |
Gender | − 0.1514 | 0.8595 | 0.6312 | 1.1703 | − 0.9615 | 0.3363 |
AJCC_T_stage | 0.69193 | 1.9976 | 1.7208 | 2.3189 | 9.0928 | 9.66E−20 |
Our sets (n = 53) | ||||||
Risk.socre | 1.4865 | 4.4217 | 2.0409 | 9.5799 | 3.7685 | 0.0002 |
TNM.stag1ng | − 0.1199 | 0.887 | 0.5506 | 1.429 | − 0.4929 | 0.6221 |
Gender | 0.6561 | 1.9273 | 0.6694 | 5.5486 | 1.2161 | 0.2239 |
Age | 0.0031 | 1.0031 | 0.407 | 2.4722 | 0.0067 | 0.9946 |